158 related articles for article (PubMed ID: 9379657)
21. Transorbital approach to decompression in Graves' disease.
Anderson RL; Linberg JV
Arch Ophthalmol; 1981 Jan; 99(1):120-4. PubMed ID: 6893929
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic orbital decompression for Graves' ophthalmopathy.
Tang IP; Prepageran N; Shashinder S
Med J Malaysia; 2008 Mar; 63(1):67-8. PubMed ID: 18935740
[TBL] [Abstract][Full Text] [Related]
23. Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy.
Marcocci C; Bartalena L; Bogazzi F; Bruno-Bossio G; Pinchera A
Exp Clin Endocrinol; 1991 May; 97(2-3):332-7. PubMed ID: 1915652
[No Abstract] [Full Text] [Related]
24. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
Wakelkamp IM; Prummel MF; Wiersinga WM
Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
[TBL] [Abstract][Full Text] [Related]
25. Orbital decompression in Graves ophthalmopathy.
Anderson RL
Trans New Orleans Acad Ophthalmol; 1982; 30():18-40. PubMed ID: 6896938
[No Abstract] [Full Text] [Related]
26. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
Wei RL; Cheng JW; Cai JP
Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
[TBL] [Abstract][Full Text] [Related]
27. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease.
Bunevicius R; Velickiene D; Prange AJ
Gen Hosp Psychiatry; 2005; 27(2):133-9. PubMed ID: 15763125
[TBL] [Abstract][Full Text] [Related]
28. Transnasal endoscopic orbital decompression and Graves' ophtalmopathy.
Eloy P; Trussart C; Jouzdani E; Collet S; Rombaux P; Bertrand B
Acta Otorhinolaryngol Belg; 2000; 54(2):165-74. PubMed ID: 10892506
[TBL] [Abstract][Full Text] [Related]
29. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
[TBL] [Abstract][Full Text] [Related]
31. [Surgical management of thyroid orbitopathy].
Pecold-Stepniewska H; Stepniewski J; Karolczak-Kulesza M; Gotz-Wieckowska A; Stepniewski S
Przegl Lek; 2004; 61(8):848-51. PubMed ID: 15789914
[TBL] [Abstract][Full Text] [Related]
32. [Grave's and Basedow's thyroid associated ophthalmopathy--pathogenesis, symptoms and selected aspects of treatment].
Nowak M; Kos-Kudła B
Klin Oczna; 2000; 102(6):455-60. PubMed ID: 11392809
[TBL] [Abstract][Full Text] [Related]
33. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
Mourits MP
Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
[No Abstract] [Full Text] [Related]
34. Management of Graves' ophthalmopathy.
Wiersinga WM
Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):396-404. PubMed ID: 17452966
[TBL] [Abstract][Full Text] [Related]
35. Decreased nerve growth factor levels in hyperthyroid Graves' ophthalmopathy highlighting the role of neuroprotective factor in autoimmune thyroid diseases.
Molnár I; Bokk A
Cytokine; 2006 Aug; 35(3-4):109-14. PubMed ID: 17008110
[TBL] [Abstract][Full Text] [Related]
36. High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves' ophthalmopathy.
Pigeon P; Orgiazzi J; Berthezene F; Gerard JP; Haguenauer JP; Mornex R
Horm Res; 1987; 26(1-4):172-6. PubMed ID: 3110042
[TBL] [Abstract][Full Text] [Related]
37. [Endocrine orbital diseases].
Síbl O; Síblová O; Veselý J
Cesk Otolaryngol; 1989 May; 38(3):129-36. PubMed ID: 2758469
[TBL] [Abstract][Full Text] [Related]
38. Graves' disease: clinical correlation with autoantibody activity.
Valente WA
Md Med J; 1988 Nov; 37(11):866-9. PubMed ID: 3054388
[No Abstract] [Full Text] [Related]
39. Old and new: evidence-based evaluation of interventions for Graves' Orbitopathy.
Ezra DG; Rose GE
Br J Ophthalmol; 2014 Mar; 98(3):287-8. PubMed ID: 24311524
[No Abstract] [Full Text] [Related]
40. Graves' hyperthyroidism and endocrine ophthalmopathy--one or two closely related diseases?
Volpé R
Dev Ophthalmol; 1993; 25():101-11. PubMed ID: 8359344
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
